Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients

Detalles Bibliográficos
Autores principales: Solera, Javier T, Ierullo, Matthew, Arbol, Berta G, Mavandadnejad, Faranak, Kurtesi, Alexandra, Qi, Freda, Hu, Queenie, Gingras, Anne-Claude, Ferreira, Victor H, Humar, Atul, Kumar, Deepali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281643/
https://www.ncbi.nlm.nih.gov/pubmed/37352879
http://dx.doi.org/10.1016/S1473-3099(23)00357-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281643/
https://www.ncbi.nlm.nih.gov/pubmed/37352879
http://dx.doi.org/10.1016/S1473-3099(23)00357-2

Ejemplares similares